
BioLife Solutions BLFS
€ 23.20
-2.72%
Quartalsbericht 2026-Q1
hinzugefügt 07.05.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBAL |
Anteile |
47.8 M |
Marktkapitalisierung |
$ 1.28 B |
EBITDA (LTM) |
$ -16.5 M |
P/E (LTM) |
-74.58 |
P/S (LTM) |
10.15 |
EPS (LTM) |
-0.31 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 67.67 | -1.39 % | $ 13.5 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 122.47 | -3.14 % | $ 7 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Intuitive Surgical
ISRG
|
$ 413.89 | -2.98 % | $ 148 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 66.2 | -2.5 % | $ 40.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 141.02 | -0.69 % | $ 3.47 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 113.59 | -0.21 % | $ 3.64 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.97 | -0.88 % | $ 183 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 92.67 | -4.06 % | $ 2.1 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.8 | -1.1 % | $ 82.4 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.38 | -0.96 % | $ 31.2 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Merit Medical Systems
MMSI
|
$ 66.73 | -1.16 % | $ 3.95 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 10.03 | 5.3 % | $ 85.1 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.16 | -1.75 % | $ 4.06 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 78.82 | 0.1 % | $ 3.72 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 206.71 | -2.9 % | $ 20.3 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 29.46 | -1.39 % | $ 1.46 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.9 | -1.22 % | $ 184 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 132.31 | -2.53 % | $ 5.9 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 69.0 | 1.37 % | $ 224 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 332.01 | -0.87 % | $ 24 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 24.97 | -3.1 % | $ 1.68 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.12 | -3.39 % | $ 2.02 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 1.0 % | $ 21 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 62.32 | -4.12 % | $ 205 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Stereotaxis
STXS
|
$ 1.83 | -1.35 % | $ 166 M | NYSE American | ||
|
Baxter International
BAX
|
$ 20.47 | 2.2 % | $ 10.5 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 194.63 | -1.17 % | $ 28.4 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.4 | 0.37 % | $ 1.31 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.2 | 2.65 % | $ 275 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 12.31 | -0.28 % | $ 503 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 148.35 | -2.43 % | $ 42.7 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.24 | -0.31 % | $ 34.4 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.04 | -4.83 % | $ 297 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 131.57 | 1.1 % | $ 7.4 M | Nasdaq Global Select Market,SPB |